Lexicon Pharmaceuticals
Price & Volume
Stats
See moreOpen | $1.64 |
Previous Close | $1.68 |
Day Range | $1.61-$1.66 |
52W Range | $1.10-$2.68 |
Market Cap | $747.5M |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $41.4M |
Revenue Growth (YoY) | -97.6% |
Gross Profit (12 Mos) | $35.6M |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 15 days ago
Lexicon a new overweight at Cantor on optimism for Inpefa in cardiomyopathy
Yahoo Finance • 2 months ago
Novo Nordisk (CPSE:NOVO B) Reaches LX9851 Obesity Drug Milestone
Yahoo Finance • 2 months ago
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
Yahoo Finance • 2 months ago
Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ...
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |